1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
662A941AA3E965E8D85256C06006AA15D
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/restructuring-managing-reorganization?opendocument
18
19opendocument
2018.97.9.171
21
22
23
24/bestp/domrep.nsf
25DB




» Products & Services » » Business Operations » Manufacturing » Restructuring

Restructuring: Managing Reorganization

DB Image

ID: 4287


Features:

Graphics


Words: 1,893


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Best Practices, LLC initiated this benchmarking study to uncover how companies redesign their structures and assume leaner operational strategies that better reflect and support corporate values. Seven benchmark facilities were selected from sterile, pharmaceutical and chemical manufacturers as well as large pharmaceutical and biotechnology companies. Benchmark partners stress the critical importance of sound reorganization management. Business disruptions and distracted employees can sink the most effective new structure before it is even in place. Leading companies engage in extensive communication campaigns to gather employee input and secure buy-in for major reorganizations. Attaching compensation plans to reorganization success also proves effective in gaining widespread employee support. This seven-page document includes best practices that partners identified for designing the reorganization process, managing reorganization activities, communicating before, during and after reorganization, maintaining productivity during the reorganization process, and reviewing and revising reorganization goals.


This study will serve as a benchmark for pharmaceutical manufacturing facilities undergoing organizational redesign to manage a change process that allows the company to continue operations while implementing significant structural changes. It will provide insights into designing a reorganization process that sufficiently plans for changes to align strategy with corporate redesign.


Industries Profiled:
Pharmaceutical; Biotech


Companies Profiled:

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.